Construction of Pfizer-sponsored pharmaceutical factory starts in Russia

31 May 2017

Construction.ru

A ground-breaking ceremony of a pharmaceutical factory was held on Tuesday in Vorsino technology park located near the Russian city of Kaluga. American company Pfizer is an investor of the enterprise's building project.

According to TASS news agency, the main partner of the project is NovaMedica, a portfolio company of the Russian government-owned company Rusnano engaged in the development of nanotechnology.

Speaking at the ceremony, Chairman of Rusnano’s Board Anatoly Chubais said that NovaMedica has barely started the construction of its factory, but it is already having the sales volume amounting to 1 billion rubles on the Russian market.

A third of medical drugs that will be manufactured at the enterprise under a license of Pfizer are not currently produced in the territory of Russia.

Source

Print

Shareholders

Read more

Pipeline

Read more

Media Center

Read more